Catalyst Pharmaceuticals Q1 2026 Earnings EPS Surpasses Estimates by 75 Trump Stock Trade Disclosure Reveals Active Big Tech Positions in Q1 2026 Amplitech Group AMPGR Q1 2026 Earnings Stock Surges 55 Despite EPS Miss Investor Optimism Drives Rally Legal Turbulence Erupts States Challenge Prediction Markets as Regulators Weigh In GALT Q1 2026 Earnings Narrowed Loss Amid Clinical Progress Stock Rally ACGLN Q1 2026 Earnings Preferred Shares React to Slight EPS Miss